PEG-MGF
Also known as: PEGylated Mechano Growth Factor, Polyethylene Glycol-MGF, Long-acting MGF
PEG-MGF is a research compound not approved for human use. For informational purposes only.
Overview
PEG-MGF is Mechano Growth Factor (MGF) conjugated to a polyethylene glycol (PEG) polymer chain. The PEGylation dramatically extends the half-life from ~5 minutes (native MGF) to approximately 24–72 hours, allowing less frequent dosing and systemic distribution rather than purely local action. This trade-off — longer duration vs localized intensity — makes PEG-MGF a different tool than native MGF, better suited for systemic muscle recovery support and convenience-focused protocols.
Research Summary
PEGylation is a validated pharmaceutical strategy for extending peptide half-life (used in Pegasys/interferon, Somavert/pegvisomant, and others). The PEG chain shields the MGF peptide from proteolytic degradation and slows renal clearance. Research in rodent models confirms PEG-MGF preserves the biological activity of native MGF (satellite cell activation, muscle repair) with extended duration. Unlike native MGF which requires precise post-workout injection timing, PEG-MGF can be injected on a scheduled basis and still achieves systemic muscle-wide satellite cell effects.
Dosing Range
low
100mcg
moderate
200mcg
high
400mcg
Units: mcg · Frequency: 2x weekly (Monday/Thursday or similar split)
Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.
Administration Routes
Reconstitution Notes
Reconstitute with bacteriostatic water to 1mg/mL. The PEG modification makes PEG-MGF significantly more stable than native MGF — stable 28 days refrigerated after reconstitution. Does not require immediate post-workout injection. 2x weekly dosing provides consistent systemic MGF exposure.Step-by-step reconstitution guide →
Supplies you'll need
Affiliate links — Research Stack may earn a small commission at no extra cost to you.
Reported Side Effects
- Hypoglycemia (less pronounced than IGF-1 DES, more than native MGF due to systemic distribution)
- Generalized fatigue on injection days
- PEG accumulation concern with very high doses over long periods (theoretical — not established at research doses)
- Localized injection site swelling
Research Papers
2 peer-reviewed sourcesCommunity Experiences
Aggregated from public forums. Anecdotal — not clinical evidence.
Community protocols comparing native MGF (post-workout local) vs PEG-MGF (scheduled systemic) — preference and results.
View original threadBodybuilding community protocols using PEG-MGF twice weekly alongside GH peptide stacks.
View original threadOverview
The fundamental problem with native MGF is pharmacokinetics: a half-life of ~5 minutes means the vast majority of an injected dose is degraded before it can exert meaningful systemic effects. PEG-MGF addresses this with PEGylation — attachment of a polyethylene glycol polymer chain that acts as a molecular "shield" against peptidases and renal filtration.
PEGylation: The Technology
PEGylation is a well-established pharmaceutical strategy. Approved PEGylated drugs include:
- Pegasys (PEG-interferon alpha-2a) — hepatitis C
- Somavert (pegvisomant) — acromegaly
- Macugen (pegaptanib) — macular degeneration
- Multiple PEGylated antibodies and enzymes
The PEG chain is biologically inert but creates a steric "cloud" around the peptide that:
- Blocks protease access (prevents degradation)
- Increases hydrodynamic radius (slows renal filtration)
- Reduces immune recognition
The result for MGF: half-life extends from ~5 minutes to 24–72 hours.
MGF vs PEG-MGF: Choosing the Right Form
| Use Case | Recommended Form | |----------|-----------------| | Post-workout local muscle hypertrophy | Native MGF (intramuscular, immediate post-workout) | | Systemic muscle recovery support | PEG-MGF (subcutaneous, 2x weekly) | | Injury recovery (systemic) | PEG-MGF | | Convenience / less frequent dosing | PEG-MGF | | Most intense local effect | Native MGF |
Many advanced protocols use both: native MGF post-workout for acute local stimulus, plus PEG-MGF twice weekly for background systemic muscle support.
Systemic vs Local Action
While native MGF is primarily local (injected into worked muscle, acts there), PEG-MGF distributes systemically. This means:
- Muscles that weren't directly trained still receive MGF signal
- Full-body recovery support even with split training
- More relevant to injury rehab where the injured site may not be exercised
Protocol Integration
PEG-MGF integrates easily into GH peptide protocols:
- Morning: Mod-GRF(1-29) + Ipamorelin
- Post-workout: Additional GH peptide dose
- Monday/Thursday: PEG-MGF 200mcg subcutaneous
This provides pulsatile GH support plus scheduled systemic IGF-1/MGF signaling.
Related Performance Peptides
CJC-1295
PerformanceCJC-1295 DAC · CJC-1295 without DAC (Mod GRF 1-29)
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to release gro…
CJC-1295 / Ipamorelin Stack
PerformanceCJC-1295 Ipamorelin · Mod GRF 1-29 Ipamorelin
The CJC-1295 (without DAC) and Ipamorelin combination is the most widely researched and community-validated growth hormo…
Follistatin 344
PerformanceFST-344 · Follistatin isoform 344
Follistatin 344 is a 344-amino acid isoform of follistatin — an endogenous glycoprotein that functions primarily as a my…
Want to calculate your dose? Use the dosing calculator →